"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
J Steroid Biochem Mol Biol
; 203: 105751, 2020 10.
Article
em En
| MEDLINE
| ID: mdl-32871238
Palavras-chave
1α, 25(OH)2D or 1α, 25-dihydroxyvitamin D or calcitriol; Acute respiratory distress syndrome (ARDS); COVID-19; Calcifediol or 25-hydroxyvitamin D3; Cathelicidin peptide; Chloroquine; Covidiol; Cuboidal alveolar coating cells type II; Cytokine/Chemokine storm; Defensins; Hydroxychloroquine; Hypercoagulability; Neutrophil activity; Renin-angiotensin system; SARS-CoV-2; TLR co-receptor CD14; Vitamin D; Vitamin D endocrine system; Vitamin D receptor; Vitamin D3 or cholecalciferol
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Calcifediol
/
Infecções por Coronavirus
/
Conservadores da Densidade Óssea
/
Betacoronavirus
/
Hospitalização
/
Unidades de Terapia Intensiva
Tipo de estudo:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article